HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,391,385 | +17.8% | 46,602 | +4.7% | 0.11% | +11.0% |
| Q2 2023 | $4,576,825 | +0.7% | 44,500 | +6.8% | 0.10% | -9.1% |
| Q1 2023 | $4,546,663 | +2.0% | 41,659 | +6.3% | 0.11% | -12.0% |
| Q4 2022 | $4,457,887 | +113.0% | 39,173 | +15.8% | 0.12% | +98.4% |
| Q3 2022 | $2,093,000 | +17.3% | 33,819 | +51.2% | 0.06% | +10.5% |
| Q2 2022 | $1,784,000 | -22.2% | 22,365 | +2.6% | 0.06% | -19.7% |
| Q1 2022 | $2,293,000 | +163.6% | 21,790 | +169.8% | 0.07% | +153.6% |
| Q4 2021 | $870,000 | +15.8% | 8,076 | +17.8% | 0.03% | -6.7% |
| Q3 2021 | $751,000 | +6.8% | 6,855 | -8.7% | 0.03% | 0.0% |
| Q2 2021 | $703,000 | -84.4% | 7,508 | -84.6% | 0.03% | -85.0% |
| Q1 2021 | $4,495,000 | +203.1% | 48,833 | +140.8% | 0.20% | +308.2% |
| Q4 2020 | $1,483,000 | -22.0% | 20,279 | -71.0% | 0.05% | +44.1% |
| Q3 2019 | $1,902,000 | – | 69,852 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |